Heterogeneous Distribution and Absorbed Dose of Radiolabeled Nanoparticles and Colloids in Sentinel Lymph Nodes
Cancer Biotherapy and Radiopharmaceuticals · 2025
DOI: 10.1089/cbr.2024.0111 ↗Kurz gefasst
Fachartikel in der Zeitschrift Cancer Biotherapy and Radiopharmaceuticals, 2025. Verfasst von Renata Madru und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Clinical Sciences Lund, Medical Radiation Physics, Lund University, Lund, Sweden. Hauptthemen laut MEDLINE: Sentinel Lymph Node, Breast Neoplasms, Radiopharmaceuticals, Technetium Tc 99m Aggregated Albumin. Die Arbeit nennt 36 Literaturangaben.
Abstract (Originalsprache)
Background
For breast cancer staging, radiolabeled colloids and superparamagnetic iron oxide nanoparticles (SPIONs) are used for sentinel lymph node (SLN) imaging. This study characterized the intranodal activity distribution and absorbed dose distribution. Material and Methods: Six patients diagnosed with primary breast cancer were intradermally injected with 99mTc-Nanocoll. The SLNs were resected, weighed, and measured for activity. Three groups of six rats were subcutaneously injected into the hind paw with either 99mTc-Nanocoll, 99mTc-SPIONs, or 68Ga-SPIONs. Macro- and small-scale dosimetry calculations were performed using autoradiography images of cryosections of SLNs from patients and animals.
Results
The mean absorbed dose in patient SLNs was 0.5 ± 0.3 mGy/MBq for 99mTc-Nanocoll and 3.4 ± 1.8 mGy/MBq, assuming a 99mTc-Nanocoll-based distribution of 68Ga-SPIONs. Due to different decay characteristics, the heterogeneity in the absorbed dose differed between 99mTc-SPIONs and 68Ga-SPIONs with a maximum to mean absorbed dose ratio of 2.7 ± 0.3 and 1.6 ± 0.2, respectively.
Conclusions
This study shows that 99mTc- and 68Ga-SPIONs and 99mTc-nanocolloids have similar activity distribution in human and animal lymph nodes. Small-scale dosimetry models combined with clinical patient biokinetics may serve as a bridge between organ and tissue dosimetry and the interpretation of intrinsic geometric variation and its uncertainties in absorbed dose.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Clinical Sciences Lund, Medical Radiation Physics, Lund University, Lund, Sweden.
- Department of Radiation Physics, Skåne University Hospital, Lund, Sweden.
- Department of Clinical Sciences Lund, Section of Oncology, Lund University, Lund, Sweden.
- Department of Clinical Sciences Lund, Surgery, Lund University, Lund, Sweden.
- Department of Clinical Sciences Lund, Pathology, Lund University, Lund, Sweden.
- F.M. Kirby Research Center for Functional Brain Imaging, Kennedy Krieger Institute, Baltimore, Maryland, USA.
ORCID-Profile: Renata Madru, Anders Örbom
Zitieren
APA
Madru, R., Larsson, E., Örbom, A., Ingvar, C., Grabau, D., Knutsson, L., & Strand, S. E. (2025). Heterogeneous Distribution and Absorbed Dose of Radiolabeled Nanoparticles and Colloids in Sentinel Lymph Nodes. Cancer Biotherapy and Radiopharmaceuticals. https://doi.org/10.1089/cbr.2024.0111
Vancouver
Madru R, Larsson E, Örbom A, Ingvar C, Grabau D, Knutsson L, et al. Heterogeneous Distribution and Absorbed Dose of Radiolabeled Nanoparticles and Colloids in Sentinel Lymph Nodes. Cancer Biotherapy and Radiopharmaceuticals. 2025. doi:10.1089/cbr.2024.0111
BibTeX
@article{Madru2025,
author = {Madru, Renata and Larsson, Erik and Örbom, Anders and Ingvar, Christian and Grabau, Dorthe and Knutsson, Linda and Strand, Sven-Erik},
title = {Heterogeneous Distribution and Absorbed Dose of Radiolabeled Nanoparticles and Colloids in Sentinel Lymph Nodes},
journal = {Cancer Biotherapy and Radiopharmaceuticals},
year = {2025},
doi = {10.1089/cbr.2024.0111}
}
EUVIMED